Clinical Trial Update: Enhancing the Secondary Prevention of Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating strategies to enhance secondary prevention in coronary artery disease has completed. The study was sponsored by the Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: University of Alberta | Conditions: Coronary Disease, Ischemic Heart Disease | Phase 4 | Status: COMPLETED